Oncology Resources
This section contains educational resources and information relating to SMPA-approved medicines and therapeutic areas of interest with healthcare professionals. The documents and response obtained from this search may contain information that is not included in the approved product label. SMPA does not promote the use of its products in a manner not consistent with the approved product label. Please refer to the Full Prescribing Information for important treatment and safety considerations.
Prescribing Information for ORGOVYX® (relugolix)
ORGOVYX® is a registered trademark of SMPA.
Download NowClinical Guidelines Update for Relugolix: Principles of ADT
This presentation represents a summary of U.S. clinical practice guidelines as described in recent updates. This approved medical affairs material provides details on the recommended use of androgen deprivation therapy across the prostate cancer continuum.
Download NowNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Prostate Cancer Version 4.2024
Principles of Androgen Deprivation Therapy, PROS-G. Reproduced with permission from the NCCN Guidelines for Prostate Cancer V.4.2024.
Download NowDidn’t find what you were looking for?
Medical Information Call Center
1-800-739-0565
Mon-Fri 9am-7pm ET (6am-4pm PT)
medinfo@us.sumitomo-pharma.com
Enter your zip code below to connect with a Medical Science Liaison (MSL) in your region.